Standard

Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin. / Grigorieva, D. V.; Gorudko, I. V.; Kostevich, V. A.; Vasilyev, V. B.; Cherenkevich, S. N.; Panasenko, O. M.; Sokolov, A. V.

In: Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, Vol. 12, No. 2, 01.04.2018, p. 136-142.

Research output: Contribution to journalArticlepeer-review

Harvard

Grigorieva, DV, Gorudko, IV, Kostevich, VA, Vasilyev, VB, Cherenkevich, SN, Panasenko, OM & Sokolov, AV 2018, 'Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin', Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, vol. 12, no. 2, pp. 136-142. https://doi.org/10.1134/S199075081802004X

APA

Grigorieva, D. V., Gorudko, I. V., Kostevich, V. A., Vasilyev, V. B., Cherenkevich, S. N., Panasenko, O. M., & Sokolov, A. V. (2018). Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 12(2), 136-142. https://doi.org/10.1134/S199075081802004X

Vancouver

Grigorieva DV, Gorudko IV, Kostevich VA, Vasilyev VB, Cherenkevich SN, Panasenko OM et al. Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2018 Apr 1;12(2):136-142. https://doi.org/10.1134/S199075081802004X

Author

Grigorieva, D. V. ; Gorudko, I. V. ; Kostevich, V. A. ; Vasilyev, V. B. ; Cherenkevich, S. N. ; Panasenko, O. M. ; Sokolov, A. V. / Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin. In: Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2018 ; Vol. 12, No. 2. pp. 136-142.

BibTeX

@article{5a51169e0b1e442ebb97801c192c02f0,
title = "Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin",
abstract = "Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.",
keywords = "degranulation, elastase, heparin, lysozyme, myeloperoxidase, neutrophils",
author = "Grigorieva, {D. V.} and Gorudko, {I. V.} and Kostevich, {V. A.} and Vasilyev, {V. B.} and Cherenkevich, {S. N.} and Panasenko, {O. M.} and Sokolov, {A. V.}",
year = "2018",
month = apr,
day = "1",
doi = "10.1134/S199075081802004X",
language = "English",
volume = "12",
pages = "136--142",
journal = "Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry",
issn = "1990-7508",
publisher = "МАИК {"}Наука/Интерпериодика{"}",
number = "2",

}

RIS

TY - JOUR

T1 - Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin

AU - Grigorieva, D. V.

AU - Gorudko, I. V.

AU - Kostevich, V. A.

AU - Vasilyev, V. B.

AU - Cherenkevich, S. N.

AU - Panasenko, O. M.

AU - Sokolov, A. V.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.

AB - Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.

KW - degranulation

KW - elastase

KW - heparin

KW - lysozyme

KW - myeloperoxidase

KW - neutrophils

UR - http://www.scopus.com/inward/record.url?scp=85047840366&partnerID=8YFLogxK

U2 - 10.1134/S199075081802004X

DO - 10.1134/S199075081802004X

M3 - Article

AN - SCOPUS:85047840366

VL - 12

SP - 136

EP - 142

JO - Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry

JF - Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry

SN - 1990-7508

IS - 2

ER -

ID: 42247502